Cargando…

Utility of coronary artery calcium in refining 10-year ASCVD risk prediction using a Thai CV risk score

BACKGROUND: Coronary artery calcium (CAC) scanning is a valuable additional tool for calculating the risk of cardiovascular (CV) events. We aimed to determine if a CAC score could improve performance of a Thai CV risk score in prediction of 10-year atherosclerotic cardiovascular disease (ASCVD) risk...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tiansuwan, Noppanat, Sasiprapha, Thinnakrit, Jongjirasiri, Sutipong, Unwanatham, Nattawut, Thakkinstian, Ammarin, Laothamatas, Jiraporn, Limpijankit, Thosaphol
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10652894/ https://www.ncbi.nlm.nih.gov/pubmed/38028497 http://dx.doi.org/10.3389/fcvm.2023.1264640

Ejemplares similares

Causal Relationship of Coronary Artery Calcium on Myocardial Infarction and Preventive Effect of Antiplatelet Therapy
por: Limpijankit, Thosaphol, et al.
Publicado: (2022)

Predictive values of coronary artery calcium and arterial stiffness for long‐term cardiovascular events in patients with stable coronary artery disease
por: Limpijankit, Thosaphol, et al.
Publicado: (2022)

Arterial stiffness contributes to coronary artery disease risk prediction beyond the traditional risk score (RAMA-EGAT score)
por: Yingchoncharoen, Teerapat, et al.
Publicado: (2012)

Evaluation of transitions from early hypertension to hypertensive chronic kidney disease, coronary artery disease, stroke and mortality: a Thai real-world data cohort
por: Teza, Htun, et al.
Publicado: (2023)

Factors associated with health-related quality of life in patients undergoing percutaneous coronary intervention: Thai PCI registry
por: Siriyotha, Sukanya, et al.
Publicado: (2023)

No Paradoxical Effect of Smoking Status on Recurrent Cardiovascular Events in Patients Following Percutaneous Coronary Intervention: Thai PCI Registry
por: Limpijankit, Thosaphol, et al.
Publicado: (2022)

Causal relationship of excess body weight on cardiovascular events through risk factors
por: Limpijankit, Thosaphol, et al.
Publicado: (2022)

Hemoglobin A1c in combination with fasting plasma glucose trumps fasting plasma glucose alone as predictive indicators for diabetes mellitus: an ambidirectional cohort study of Thai people with impaired fasting glucose
por: Thamakaison, Sangsulee, et al.
Publicado: (2021)

Can we measure iron overload in the heart using in vivo MRI T2*?
por: He, Taigang, et al.
Publicado: (2009)

Cardio‐ankle vascular index as a predictor of major adverse cardiovascular events in metabolic syndrome patients
por: Limpijankit, Thosaphol, et al.
Publicado: (2021)

Effects of Oral Procaterol for Postinfectious Cough in Adults: Single-Centre, Randomized Double-Blind, Placebo-Controlled Trial
por: Pornsuriyasak, Prapaporn, et al.
Publicado: (2021)

Metabolomics profile and 10-year atherosclerotic cardiovascular disease (ASCVD) risk score
por: Dehghanbanadaki, Hojat, et al.
Publicado: (2023)

Dose‐dependent effect of impaired renal function on all‐cause mortality in patients following percutaneous coronary intervention
por: Limpijankit, Thosaphol, et al.
Publicado: (2022)

Gauging ASCVD Risk, Does Race Matter?
por: Zuo, Ming-Liang, et al.
Publicado: (2022)

Association of hyperuricemia combined with sarcopenia on ASCVD risk
por: Nie, Guqiao, et al.
Publicado: (2023)

Effect of Lipophilic and Hydrophilic Statins on Breast Cancer Risk in Thai Women: A Cross-sectional Study
por: Anothaisintawee, Thunyarat, et al.
Publicado: (2016)

ASCVD risk stratification modifies the effect of HbA1c on cardiovascular events among patients with type 2 diabetes mellitus with basic to moderate risk
por: Zhang, Hongmei, et al.
Publicado: (2020)

The Potential Role of Biomarkers Associated with ASCVD Risk: Risk-Enhancing Biomarkers
por: Choi, Seonghoon
Publicado: (2019)

Patient Characteristics, Procedural Details, and Outcomes of Contemporary Percutaneous Coronary Intervention in Real-World Practice: Insights from Nationwide Thai PCI Registry
por: Sansanayudh, Nakarin, et al.
Publicado: (2022)

IMPACT OF THE COVID-19 PANDEMIC ON THE MANAGEMENT OF RISK FACTORS IN PATIENTS WITH ASCVD
por: Karalis, Dean, et al.
Publicado: (2023)

Prevalence of Vitamin D insufficiency and low bone mineral density in elderly Thai nursing home residents
por: Kruavit, Anuk, et al.
Publicado: (2012)

SAT-613 Comparison of CV Risk Scores to Evaluate Cardiovascular Risks in Thai Type 2 Diabetes
por: Waisayanand, Nipawan, et al.
Publicado: (2020)

A tool to help patients visualize ASCVD risk and the potential impact of risk-lowering interventions
por: Mendez, Keegan, et al.
Publicado: (2022)

Combination of Endoglin and ASCVD Risk Assessment Improves Carotid Subclinical Atherosclerosis Recognition
por: Li, Qiaowei, et al.
Publicado: (2020)

RELATION OF 10-YEAR ASCVD RISK SCORE WITH SEVERE COVID-19 OUTCOMES
por: Arif, Yousif, et al.
Publicado: (2022)

Newer and Emerging LDL-C Lowering Agents and Implications for ASCVD Residual Risk
por: Rikhi, Rishi, et al.
Publicado: (2022)

Comparison of Framingham Cardiovascular Risk Criteria and ASCVD Score in Iranian Obese Patients
por: Hasani-Ranjbar, Shirin, et al.
Publicado: (2023)

Highlights in ASCVD Primary Prevention for 2021
por: Polonsky, Tamar S., et al.
Publicado: (2022)

Dialysate Magnesium and Coronary Artery Calcification, Bone Mineral Density, and Cramping in Maintenance Hemodialysis: A Quasi-experimental Study
por: Srisuwarn, Praopilad, et al.
Publicado: (2021)

Effects of second-line antihyperglycemic drugs on the risk of chronic kidney disease: applying a target trial approach to a hospital-based cohort of Thai patients with type 2 diabetes
por: Siriyotha, Sukanya, et al.
Publicado: (2022)

COVID-19 associated risks of myocardial infarction in persons with familial hypercholesterolemia with or without ASCVD
por: Myers, Kelly D., et al.
Publicado: (2021)

External validation of the ACC/AHA ASCVD risk score in a Colombian population cohort
por: Rodríguez-Ariza, Carlos Daniel, et al.
Publicado: (2023)

Abnormal plasma ceramides refine high-risk patients with worsening heart failure
por: Ren, Lu, et al.
Publicado: (2023)

Health Literacy is Essential to ASCVD Prevention in Youth
por: Mann, Harnoor K., et al.
Publicado: (2023)

10-year ASCVD risk is positively correlated with depressive symptoms in a large general population
por: Sun, Guo-Zhe, et al.
Publicado: (2019)

Identifying Opportunities for Impact of Community-Based Pharmacist-Led Biometric Health Screenings on ASCVD Risk
por: Newell, Bradley J., et al.
Publicado: (2023)

Gender-Related Differences in Chest Pain Syndromes in the Frontiers in CV Medicine Special Issue: Sex & Gender in CV Medicine
por: Mehta, Puja K., et al.
Publicado: (2021)

Frequency of cardioversions as an additional risk factor for stroke in atrial fibrillation – the FinCV-4 study
por: Jaakkola, Samuli, et al.
Publicado: (2022)

Effects of weight change on apolipoprotein B-containing emerging atherosclerotic cardiovascular disease (ASCVD) risk factors
por: Dansinger, Michael L., et al.
Publicado: (2019)

Effects of intensive lipid lowering compared with moderate-intensity lipid lowering on coronary atherosclerotic plaque phenotype and major adverse cardiovascular events in adults with low to intermediate 10-year ASCVD risk (ILLUMINATION study): protocol for a multicentre, open-label, blinded-endpoint, randomised controlled trial
por: Zheng, Jianan, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_nscls2vmtvet70ecvko5ic8f5u